Salicylate Regulates COX‐2 Expression Through ERK and Subsequent NF‐κB Activation in Osteoblasts
Authors:
- Han‐Jung ChaeHan‐Jung Chae
- Soo‐Wan ChaeSCSoo‐Wan Chae
- John C. ReedJRJohn C. Reed
- Hyung‐Ryong KimHKHyung‐Ryong Kim
- 1 January 2004
- journal article
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 26 (1) , 75-91
Abstract
The expression of cyclooxygenase-2 (COX-2) is a characteristic response to inflammation and can be inhibited with sodium salicylate. TNF-alpha plus IFN-gamma can induce extracellular signal-regulated kinase (ERK), IKK, IkappaB degradation and NF-kappaB activation. The inhibition of the ERK pathway with selective inhibitor, PD098059, blocked cytokine-induced COX-2 expression and PGE2 release. Salicylate treatment inhibited COX-2 expression induced by TNF-alpha/IFN-gamma and regulated the activation of ERK, IKK and IkappaB degradation and subsequent NF-kappaB activation in MC3T3E1 osteoblasts. As well, antioxidant-catalase, N-acetyl-cysteine or reduced glutathione-attenuated COX-2 expression in combined cytokines-treated cells. These antioxidants also inhibited the activation of ERK, IKK and NF-kappaB in MC3T3E1 osteoblasts. In addition, TNF-alpha/IFN-gamma stimulated ROS release in the osteoblasts. However salicylate had no obvious effect on ROS release in DCFDA assay. The results showed that salicylate inhibited the activation of ERK and IKK, IkappaB degradation and NF-kappaB activation independent of ROS release and suggested that salicylate exerts its anti-inflammatory action in part through inhibition of the ERK, IKK, IkappaB, NF-kappaB and resultant COX-2 expression pathway.Keywords
This publication has 31 references indexed in Scilit:
- Interleukin-1β Regulation of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 Involves the p42/44 and p38 MAPK Signaling Pathways in Cardiac MyocytesHypertension, 1999
- Ceramide Regulates the Transcription of Cyclooxygenase-2Journal of Biological Chemistry, 1998
- Lipopolysaccharide-induced expression of cyclooxygenase-2 in mouse macrophages is inhibited by chloromethylketones and a direct inhibitor of NF-κB translocationProstaglandins & Other Lipid Mediators, 1998
- Induction of Cyclooxygenase-2 by the Activated MEKK1 → SEK1/MKK4 → p38 Mitogen-activated Protein Kinase PathwayJournal of Biological Chemistry, 1998
- Inhibition of Tumor Necrosis Factor-induced p42/p44 Mitogen-Activated Protein Kinase Activation by Sodium SalicylateJournal of Biological Chemistry, 1996
- Inhibition of NF-κB by Sodium Salicylate and AspirinScience, 1994
- Studies on the induction of cyclooxygenase isozymes by various prostaglandins in mouse osteoblastic cell line with reference to signal transduction pathwaysBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Tumor necrosis factor-α stimulates phosphatidylinositol breakdown by phospholipase C to coordinately increase the levels of diacylglycerol, free arachidonic acid and prostaglandins in an osteoblast (MC3T3-E1) cell lineBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1991
- Tumor necrosis factor type α (cachectin) stimulates mouse osteoblast-like cells (MC3T3-E1) to produce macrophage-colony stimulating activity and prostaglandin E2Biochemical and Biophysical Research Communications, 1987
- Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factorsNature, 1986